Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 73124 CHICAGO, IL
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$68,348
-$7,127 QoQ
Shares Held
69,743
-8.1% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ATNM ranks #369 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in ATNM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $68,348 69,743
2026-03-31 $75,475 75,855
2025-12-31 $57,949 42,610
2025-09-30 $57,432 35,895
2025-06-30 $83,987 59,991
2025-03-31 $367,517 228,272
2024-12-31 $317,431 251,930
2024-09-30 $451,421 240,118
2024-06-30 $1,690,596 228,459
2024-03-31 $1,805,636 230,605
2023-12-31 $1,150,070 226,392
2023-09-30 $1,304,672 220,384
2023-06-30 $1,627,472 219,336
2023-03-31 $421,091 44,560
2022-12-31 $476,949 44,784
2022-09-30 $289,538 39,233
2022-06-30 $183,039 38,054
2022-03-31 $190,960 37,370
2021-12-31 $228,295 37,986
2021-09-30 $339,594 38,329
2021-06-30 $300,991 38,052
2021-03-31 $206,517 27,102
2020-12-31 $213,096 27,320
2020-09-30 $261,087 26,944
2020-06-30 $298,076 846,808
2020-03-31 $61,506 317,043